Novo Nordisk diabetes pill reduces blood sugar levels in pediatric clinical trial. The findings mark a potential shift in treatment options for children diagnosed with the condition.
Novo Nordisk reports that its oral diabetes medication successfully lowered blood sugar levels in a clinical trial involving children.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Hubs
Briefings
More story pages
US temporarily bans green-card holders who visited DRC, Uganda, or South Sudan in last 21 days to prevent Ebola entry.
The US government has temporarily banned entry of green-card holders who traveled to the Democratic Republic of Congo, Uganda, or South Sudan in the past 21 days, aiming to prevent Ebola from entering the country.
Natural food dyes linked to higher Type 2 diabetes and cancer risk, new study finds. Research suggests alternatives to artificial colors may pose health concerns.
New research indicates that natural color additives, often used as alternatives to artificial food dyes, are associated with increased risks of Type 2 diabetes and cancer.
US health authorities plan to bar lawful permanent residents from reentering if they've traveled to Ebola-affected areas, per new rule published Friday
U.S. health authorities announced plans to bar lawful permanent residents from reentering the country if they have recently traveled to Ebola-affected areas, according to a new rule published Friday.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.